Christopher Lauderback
27Patents
19h-index
15Co-inventors
70Inventor score
Filing activity: Jun 1, 2004 → Sep 13, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7105486B2 | Abuse-resistant amphetamine compounds | Human Necessities | 83 | Expired |
| US7375083B2 | Pharmaceutical compositions for prevention of overdose or abuse | Human Necessities | 64 | Expired |
| US7678770B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 55 | Active |
| US7671030B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 54 | Active |
| US7223735B2 | Abuse resistant lysine amphetamine compounds | Emerging Cross-Sectional Technologies | 48 | Expired |
| US7655630B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 45 | Active |
| US7662787B2 | Abuse resistant lysine amphetamine compounds | Emerging Cross-Sectional Technologies | 43 | Active |
| US7659253B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 42 | Active |
| US7700561B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 40 | Active |
| US7671031B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7678771B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7723305B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7718619B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7674774B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7687466B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7659254B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 38 | Active |
| US7375082B2 | Abuse-resistant hydrocodone compounds | Human Necessities | 32 | Expired |
| US7687467B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 25 | Active |
| US7427600B2 | Active agent delivery systems and methods for protecting and administering active agents | Human Necessities | 21 | Expired |
| US7662788B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 16 | Active |
| US7713936B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 16 | Active |
| US7169752B2 | Compounds and compositions for prevention of overdose of oxycodone | Human Necessities | 14 | Expired |
| US8394813B2 | Active agent delivery systems and methods for protecting and administering active agents | Emerging Cross-Sectional Technologies | 13 | Active |
| US7338939B2 | Abuse-resistant hydrocodone compounds | Human Necessities | 12 | Expired |
| US7622441B2 | Sustained release pharmaceutical compounds to prevent abuse of controlled substances | Human Necessities | 8 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.